AIP
GH icon

Ameritas Investment Partners’s Guardant Health GH Stock Holding History

Ameritas Investment Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,166
Closed -$939K – 3237
2026
Q1 		$939K Buy
10,166
+132
+1% +$13.3K 0.03% 627
2025
Q4 		$1.02M Buy
10,034
+54
+0.5% +$4.83K 0.03% 604
2025
Q3 		$624K Sell
9,980
-2,216
-18% -$121K 0.02% 747
2025
Q2 		$635K Buy
12,196
+162
+1% +$7.24K 0.02% 752
2025
Q1 		$513K Sell
12,034
-312
-3% -$13.5K 0.02% 807
2024
Q4 		$377K Buy
12,346
+391
+3% +$11K 0.01% 961
2024
Q3 		$274K Buy
11,955
+692
+6% +$19.6K 0.01% 1126
2024
Q2 		$325K Sell
11,263
-430
-4% -$10K 0.01% 975
2024
Q1 		$241K Hold
11,693
– – 0.01% 1164
2023
Q4 		$316K Buy
11,693
+644
+6% +$16.9K 0.01% 993
2023
Q3 		$327K Buy
11,049
+1,866
+20% +$65.6K 0.01% 924
2023
Q2 		$329K Buy
+9,183
New +$264K 0.01% 902
2019
Q2 		– Sell
-1,196
Closed -$92K – 3075
2019
Q1 		$92K Hold
1,196
– – ﹤0.01% 1529
2018
Q4 		$45K Buy
+1,196
New +$44.1K ﹤0.01% 1874

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Ameritas Investment Partners's GH Position: Q2 2026 in Review

Ameritas Investment Partners sold out of Guardant Health (GH) in Q2 2026, closing a stake of 10,166 shares — an estimated $939K sold.

Ameritas Investment Partners first reported a position in GH in Q4 2018 and held it in 14 quarters. The position peaked at $1.02M in Q4 2025. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Ameritas Investment Partners reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Ameritas Investment Partners sold 10,166 Guardant Health shares in Q2 2026, an estimated $939K.
  • Ameritas Investment Partners first reported a position in Guardant Health in Q4 2018 and held it in 14 quarters.
  • Ameritas Investment Partners's Guardant Health position peaked at $1.02M in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.